Eli Lilly halts new studies and exports of some medicines to Russia

Pharmaceutical firm Eli Lilly, a competitor to Novo Nordisk on the US insulin scene, says it is ethically bound to protect patients, even if they live in Russia, which is heavily sanctioned.
Photo: MIKE SEGAR/REUTERS / X90033
Photo: MIKE SEGAR/REUTERS / X90033
By Riley Griffin, bloomberg

Eli Lilly & Co. said it has suspended investment, promotional activity and new clinical trials in Russia, and has stopped exporting nonessential medicines to the country, in response to the war in Ukraine.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading